Pharmafile Logo

KDS Consulting, LLC

Kim D. Slocum is President of KDS Consulting, LLC, an organization devoted to helping health care organizations understand the broader environment in which they operate and assisting them in finding strategic,sustainable solutions to the business challenges they face.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

407 Shropshire Drive, West Chester, PA, 19382, United States
+1 484-653-8252

 Latest Content from PMHub 

Webinar: Observational Research

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Webinar: The storytelling method that works for e-detailing

If you can involve healthcare professionals in a story, they will be more open to your arguments.

Understanding the ‘adoption ladder’ in closed loop marketing

Did you know that the very barriers to your product can be turned around to drive its success? Learn the judo strategy that is at the heart of great e-detailing.

Evolution of the wearable tech revolution

Stuart Goodman delves into the world of wearables, further analysing what role they play in pharma’s future.